Alpha-O Peptides AG develops technologies in therapeutics and biotechnology and licenses them to qualified industry partners. The company focuses on peptide- and protein-based self-assembling nanoparticle platforms for vaccine, antigen-display and drug-delivery applications, as reflected in its patent portfolio.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered2
Development of innovative technologies in therapeutics and biotechnology
Development of technologies in therapeutics and biotechnology, in particular based on peptide and protein nanoparticles for drug delivery and vaccine applications; licensing to qualified industrial partners.
Licensing of technologies and patents
Licensing of the patent portfolio and active patent applications to industrial partners; includes patents for peptidic and self-assembling nanoparticles for drug delivery and vaccines.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.